• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Autologous Cell Therapy Market Size

    ID: MRFR/HC/7487-HCR
    200 Pages
    Rahul Gotadki
    October 2025

    Autologous Cell Therapy Market Research Report By Application (Oncology, Cardiology, Orthopedics, Dermatology), By Cell Type (Stem Cells, T Cells, Dendritic Cells, Platelet Rich Plasma), By End-use (Hospitals, Clinics, Research Laboratories), By Technology (Cell Isolation, Cell Expansion, Cryopreservation), and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Afr...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Autologous Cell Therapy Market Infographic

    Purchase Options

    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Summary Table of Contents Segmentation Download PDF

    Autologous Cell Therapy Size

    Autologous Cell Therapy Market Growth Projections and Opportunities

    Among factors driving the autologous cell therapy market is a range of them influencing its growth and developments. One of primary forces that promote autologous cell therapy is the greater contribution invested in therapeutic potential of autologous cell treatment for treating different medical states. Several initiatives have emerged, making the concept of autologous cells use for treatment purposes popular and contributing to the increasing revival in calls for individualized and regenerative treatment options. Technological developments have a crucial role to effect on the autologous cell therapy market. The growth of further cell therapies is stemmed from the ever-evolving practices that may come to pass in cell isolation, expansion, and manipulation, including advancements technology for gene editing such as CRISPR-Cas9. This technological innovation not only enhances the performance of autologous cell therapies but also broadens their scope in terms of widening the diseases and conditions that they are to be used on. Shaping the market dynamics by cell therapy regulations is among the important aspects of cell therapies. The security, efficacy and quality of autologous cell therapies is assured by strict regulations which will be influence their approval the way in which they are commercialized and placed in clinical settings. These rules should be followed for establishing trust and market entry as trusted institution with healthcare providers, patients, and regulatory bodies. As for autologous cell therapies, the adoption rate varies in different regions due to a range of economic factors and healthcare delivery systems. Factors like the degree of healthcare utilization, reimbursement policies as well as economic status result in affecting the level at which cell therapy is used and patient demand for personalized regenerative treatments. It means that the players are operating in different landscapes and failing to produce products addressing specific challenges posed by these difference healthcare systems. The competitive situation in the market of autologous cell therapy is characterized by a constant process of innovation and development. Currently, biotechnology companies and research institutions focus on the wide range of cell therapies that could be presented with certain features available next to them such as safety and efficiency that is demonstrated in targeting specific diseases. In a competitive environment, the market players continuously face pressure to maintain leading positions in terms of innovation; such an innovative impulse facilitates bringing new technologies to the field of autologous therapies and constantly improving their properties. There are initiatives between cell therapy developers, research institutions as well as healthcare organizations that help in developing innovations in the global tissue and biopsy specimen processing market. The partnerships discussed above concentrate around initiatives like the development new cell sources, clearance of manufacturing process and advances in PMEA approaches. Cooperation between various stakeholders fiui1deceUs transforms the rate of development in autologous cell therapies that meet the demands of changing patients and healthcare workers.

    Autologous Cell Therapy Market Size Graph

    Market Summary

    The Global Autologous Cell Therapy Market is projected to grow significantly from 6.43 USD Billion in 2024 to 45.91 USD Billion by 2035.

    Key Market Trends & Highlights

    Autologous Cell Therapy Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 12.13 percent from 2025 to 2035. By 2035, the market valuation is anticipated to reach 45 USD Billion, indicating robust growth potential. in 2024, the market is valued at 6.43 USD Billion, reflecting a strong foundation for future expansion. Growing adoption of autologous cell therapy due to increasing prevalence of chronic diseases is a major market driver.

    Market Size & Forecast

    2024 Market Size 6.43 (USD Billion)
    2035 Market Size 45.91 (USD Billion)
    CAGR (2025-2035) 19.56%
    Largest Regional Market Share in 2024 latin_america)

    Major Players

    <p>Novartis, Regenative Labs, Takeda Pharmaceutical, Celgene, Gilead Sciences, Abeona Therapeutics, Celerion, Amgen, UniQure, Kite Pharma, bluebird bio, Miltenyi Biotec, Vericel Corporation, Roche, BristolMyers Squibb</p>

    Market Trends

    Growing knowledge of regenerative medicine and improvements in biomanufacturing are driving major developments in the Autologous Cell Therapy Market. The need for novel treatments that not only employ a patient's own cells but also offer individualized treatment options to improve patient outcomes has increased due to the rise in age-related disorders and chronic illnesses.

    As nations realize the promise of autologous treatments in personalized medicine, regulatory backing and actions from health authorities worldwide are also driving market expansion. There are several opportunities in this market, especially with regard to growing applications in different therapeutic areas including diabetes, cardiovascular disease, and cancer.

    More healthcare providers will have access to these medicines as a result of increased development and manufacturing opportunities brought about by the emergence of technological platforms that make cell processing and storage easier.

    Innovative product releases and improved research capacities are also being made possible by collaborations between biotechnology businesses and research institutes. Clinical studies involving autologous cell treatments have increased recently, indicating a tendency toward thorough scientific confirmation.

    Research is being translated into clinical settings more quickly as a result of growing cooperation between private businesses and academic institutions. Government support for cutting-edge healthcare solutions is causing regulatory frameworks in many areas to change to make room for these advancements, which is driving market expansion.

    Additionally, demand is being driven by patients' increasing knowledge of cellular therapies, which suggests a change in healthcare preferences toward individualized, patient-centered care. Overall, technological advancements and a positive healthcare environment are expected to propel the Autologous Cell Therapy Market's quick expansion.

     

    <p>The Global Autologous Cell Therapy Market is poised for transformative growth, driven by advancements in regenerative medicine and increasing clinical applications across various therapeutic areas.</p>

    U.S. National Institutes of Health (NIH)

    Autologous Cell Therapy Market Market Drivers

    Market Growth Projections

    Regulatory Support and Frameworks

    Regulatory support plays a pivotal role in shaping the Global Autologous Cell Therapy Market Industry. Governments are establishing frameworks that facilitate the approval and commercialization of autologous therapies. These regulations aim to ensure safety and efficacy while promoting innovation. For example, streamlined approval processes for cell-based therapies can expedite their availability to patients. This supportive environment encourages companies to invest in the development of new treatments, thereby driving market growth. As regulatory bodies continue to adapt to the evolving landscape of cell therapies, the industry is likely to experience enhanced momentum.

    Rising Prevalence of Chronic Diseases

    The Global Autologous Cell Therapy Market Industry is experiencing growth due to the increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders. These conditions often require innovative treatment approaches, and autologous cell therapy offers personalized solutions. For instance, the use of stem cells derived from a patient's own body has shown promise in treating various ailments. As the global population ages and the incidence of these diseases rises, the demand for effective therapies is expected to surge. This trend is likely to contribute to the market's projected growth, with an estimated value of 12.8 USD Billion in 2024.

    Technological Advancements in Cell Therapy

    Technological innovations are significantly shaping the Global Autologous Cell Therapy Market Industry. Advances in cell processing, gene editing, and biomanufacturing techniques enhance the efficacy and safety of therapies. For example, CRISPR technology allows for precise modifications of genetic material, potentially improving treatment outcomes. These advancements not only facilitate the development of new therapies but also streamline production processes, making treatments more accessible. As a result, the market is poised for substantial growth, with projections indicating a rise to 45 USD Billion by 2035, reflecting a compound annual growth rate of 12.13% from 2025 to 2035.

    Increased Investment in Research and Development

    Investment in research and development is a critical driver of the Global Autologous Cell Therapy Market Industry. Governments and private entities are allocating significant resources to explore the potential of autologous therapies. This funding supports clinical trials and the development of innovative treatment modalities. For instance, various initiatives aim to enhance the understanding of stem cell applications in regenerative medicine. As research progresses, new therapies are likely to emerge, further expanding the market. The anticipated growth trajectory suggests that the industry will continue to attract investment, fostering advancements that could lead to improved patient outcomes.

    Growing Awareness and Acceptance of Cell Therapies

    The Global Autologous Cell Therapy Market Industry benefits from increasing awareness and acceptance of cell therapies among healthcare professionals and patients. Educational campaigns and successful case studies are helping to demystify these treatments, leading to greater trust and demand. As patients become more informed about the potential benefits of autologous therapies, they are more likely to seek these options. This shift in perception is crucial for market expansion, as it encourages healthcare providers to incorporate these therapies into treatment protocols. Consequently, the market is expected to witness robust growth, driven by a more informed patient population.

    Market Segment Insights

    Autologous Cell Therapy Market Application Insights

    <p>The Autologous Cell Therapy Market experienced significant growth driven by various applications across diverse medical fields. Different applications highlighted the advancements in personalized medicine and an increasing preference for therapies that leveraged the body's own cells for treatment, catering to a range of serious health conditions.</p>

    <p>Oncology held a majority holding within this market, with a projected valuation of 4.5 USD Billion in 2024 and expected to rise to 16.2 USD Billion by 2035. The increasing incidence of cancer cases globally, along with a growing emphasis on targeted therapies and immunotherapy, further illustrates the importance of this application.Cardiology was another significant segment, valued at 3.2 USD Billion in 2024 and anticipated to reach 11.7 USD Billion by 2035, supported by rising cardiovascular diseases and innovations in regenerative medicine.</p>

    <p>The Orthopedics application, valued at 2.3 USD Billion in 2024 and projected to rise to 8.6 USD Billion by 2035, demonstrated the focus on tissue repair, particularly for joint and musculoskeletal conditions, showcasing the potential of autologous cell therapies in enhancing recovery processes.</p>

    Autologous Cell Therapy Market Cell Type Insights

    <p>The Autologous Cell Therapy Market, particularly within the Cell Type segment, presents a dynamic landscape with significant growth potential. Within this segment, various cell types are noteworthy; Stem Cells have garnered attention for their versatility in regenerative medicine, while T Cells are crucial in immunotherapy, enhancing the body's immune response against diseases.</p>

    <p>Dendritic Cells play a vital role in activating the immune system, demonstrating their significance in cancer treatments. Additionally, Platelet Rich Plasma is gaining traction for its applications in healing injuries and promoting tissue regeneration.The integration of advanced technologies and ongoing Research and Development activities further fuels the growth of this segment, highlighting the importance of these cell types in addressing various health challenges.</p>

    <p>The Autologous Cell Therapy Market data indicates a robust upward trend, supported by increasing investments and a focus on personalized medicine. As the industry evolves, it faces challenges such as regulatory hurdles and high manufacturing costs, yet the opportunities for innovation and market expansion remain abundant.</p>

    Autologous Cell Therapy Market End-use Insights

    <p>The Autologous Cell Therapy Market has shown substantial growth across various End-use categories, which include Hospitals, Clinics, and Research Laboratories. Hospitals play a pivotal role in the market, as they are often the primary settings for advanced treatments involving autologous cells, thereby facilitating patient care and ensuring quality outcomes.</p>

    <p>Clinics, on the other hand, contribute significantly to the growth of outpatient therapies, enabling patients to access personalized treatment modalities effectively. Research Laboratories are crucial in driving innovation, contributing to the development of new therapies and understanding the underlying mechanisms of autologous cell applications.</p>

    <p>The increasing focus on regenerative medicine, along with advancements in technology and growing investment in Research and Development, are vital growth drivers. However, challenges such as regulatory hurdles and high treatment costs may affect market uptake.</p>

    Autologous Cell Therapy Market Technology Insights

    <p>The Technology segment within this market encompasses critical processes like Cell Isolation, Cell Expansion, and Cryopreservation, which each play pivotal roles in facilitating effective cellular therapies.Cell Isolation is essential for selecting the right cells for therapy, ensuring higher success rates in treatment outcomes, while Cell Expansion enables the multiplication of these cells to meet therapeutic demands. Cryopreservation is equally significant, preserving cells for extended periods without loss of viability, thus making it vital for the logistics of patient-specific therapies.</p>

    <p>The Autologous Cell Therapy Market data shows significant interest in these technologies, driven by advancements in Research and Development, which present opportunities for enhancing therapeutic applications and addressing challenges in cancer treatments, regenerative medicine, and genetic disorders.As the market evolves, continued innovation and investment in these technology segments will likely enhance their importance and utility in the broader context of cell therapies globally.</p>

    Get more detailed insights about Autologous Cell Therapy Market Research Report - Global Forecast till 2035

    Regional Insights

    The Autologous Cell Therapy Market was notably segmented into various regions that exhibited distinct characteristics in terms of revenue generation and growth potential.In 2024, North America held a majority share with a valuation of 5.5 USD Billion, expected to grow to 18.1 USD Billion by 2035, reflecting its significant role driven by advanced healthcare infrastructure and strong Research and Development initiatives.

    Europe followed as the second-largest region, valued at 3.7 USD Billion in 2024 and projected to reach 12.1 USD Billion by 2035, being a hub for clinical research and high demand for innovative therapies.Meanwhile, Asia Pacific, with a valuation of 2.5 USD Billion in 2024, is anticipated to grow substantially to 8.0 USD Billion by 2035, fueled by rising healthcare expenditures and increasing adoption of advanced medical technologies.

    South America, albeit smaller in scale, showed potential growth from 0.8 USD Billion in 2024 to 2.6 USD Billion in 2035, highlighting an emerging market with improving healthcare access. The Middle East and Africa, valued at 0.27 USD Billion in 2024, is expected to expand to 0.9 USD Billion by 2035, representing a nascent market attracting investments in healthcare advancements.Each of these regions reflected unique opportunities and challenges within the Autologous Cell Therapy Market landscape, contributing to its overall expansion in the coming years.

    Autologous Cell Therapy Market Regional Insights

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Key Players and Competitive Insights

    The Autologous Cell Therapy Market is characterized by rapid advancements and significant competitive activity as companies strive to innovate and expand their footprint in this emerging sector of regenerative medicine.Autologous cell therapy, which utilizes a patient's own cells for treatment, is gaining traction due to its potential to minimize immune rejection and optimize therapeutic outcomes. The market is driven by an increasing prevalence of chronic diseases, advances in technology, and a growing acceptance of personalized medicine.

    As research and clinical trials progress, the competitive landscape is evolving, with players focusing on building strong intellectual property portfolios, establishing strategic partnerships, and expanding their product offerings to meet the diverse needs of patients and healthcare providers.

    Novartis has established a formidable presence in the Autologous Cell Therapy Market, leveraging its extensive resources and expertise in biotechnology. The company is particularly strong in developing innovative therapies targeting hematologic diseases and solid tumors, utilizing novel gene editing and cell manufacturing techniques.

    Novartis stands out due to its strong commitment to research and development, reflected in its substantial investments in clinical trials. These efforts have positioned the company as a leader in cell therapy, allowing it to emerge with robust product pipelines and strategic collaborations that enhance its market stature.The company's ability to navigate regulatory challenges while maintaining compliance has further solidified its competitive edge and reputation within the market.

    Regenative Labs operates within the Autologous Cell Therapy Market, focusing on solutions derived from regenerative medicine aimed at enhancing tissue repair and healing. The company specializes in regenerative products and services that harness the power of stem cells to treat various orthopedic and musculoskeletal conditions.With a growing portfolio of offerings, including tissue grafts and cellular therapies designed for quick and effective results, Regenative Labs has carved a niche market presence. Its strengths lie in leveraging innovative techniques and a commitment to quality.

    Additionally, the company's strategic partnerships and collaborations support its mission to elevate the standards of care in regenerative therapies. Mergers and acquisitions in recent years have poised Regenative Labs to broaden its market influence and adapt to the evolving industry landscape, enhancing its capability to develop cutting-edge therapies that resonate globally.

    Key Companies in the Autologous Cell Therapy Market market include

    Industry Developments

    Using EsoBiotec's in-body genetic modification technology to improve treatment speed and efficacy, AstraZeneca announced in March 17, 2025, that it would buy the company for up to $1 billion in order to expand its capabilities in autologous cell therapies for autoimmune diseases and cancer.

    The world's first Nebula-powered autologous iPSC-derived endothelial cell therapy, which targets peripheral artery and coronary artery diseases, was developed by Cellino and South Korea's Karis Bio on April 15, 2025.The two companies intend to industrialize production and start first-in-human trials. MaxCyte and Ori Biotech established a collaboration in June 2025 to improve production efficiency by streamlining closed-loop, scalable autologous cell therapy manufacturing.

    Limula has started beta testing their completely automated autologous cell-processing technology in June 2025, which is intended to streamline processes for individualized treatment. Reiterating AbbVie's post-Humira strategic expansion, the company announced in June 30, 2025, that it had acquired Capstan Therapeutics for $2.1 billion.Capstan Therapeutics is the company behind the development of CPTX2309, an autologous CAR-T candidate that targets autoimmune illnesses.

    A significant milestone for the use of autologous cell therapy beyond hematologic malignancies was reached on May 31, 2025, when the findings of China's first randomized controlled study of CAR-T treatment for solid tumors showed a 40% increase in overall survival for patients with gastric and GEJ cancer.The continued dominance of autologous CAR-T modalities was further confirmed in March 2024 when Kite Pharma (Gilead) was granted extended FDA clearance for its Yescarta CAR-T treatment in recurrent follicular lymphoma.

    Future Outlook

    Autologous Cell Therapy Market Future Outlook

    <p>The Autologous Cell Therapy Market is projected to grow at a 19.56% CAGR from 2025 to 2035, driven by advancements in regenerative medicine, increasing prevalence of chronic diseases, and rising demand for personalized therapies.</p>

    New opportunities lie in:

    • <p>Develop innovative manufacturing processes to enhance cell therapy scalability and reduce costs. Invest in R&amp;D for novel applications of autologous cells in oncology and autoimmune diseases. Forge strategic partnerships with healthcare providers to expand market access and improve patient outcomes.</p>

    <p>By 2035, the Autologous Cell Therapy Market is expected to achieve substantial growth, reflecting its critical role in modern therapeutic strategies.</p>

    Market Segmentation

    Autologous Cell Therapy Market End-use Outlook

    • Hospitals
    • Clinics
    • Research Laboratories

    Autologous Cell Therapy Market Regional Outlook

    • North America
    • Europe
    • South America
    • Asia Pacific
    • Middle East and Africa

    Autologous Cell Therapy Market Cell Type Outlook

    • Stem Cells
    • T Cells
    • Dendritic Cells
    • Platelet Rich Plasma

    Autologous Cell Therapy Market Technology Outlook

    • Cell Isolation
    • Cell Expansion
    • Cryopreservation

    Autologous Cell Therapy Market Application Outlook

    • Oncology
    • Cardiology
    • Orthopedics
    • Dermatology

    Report Scope

    Report Attribute/MetricDetails
    Market Size 202412.77(USD Billion)
    Market Size 203545.91 (USD Billion)
    Compound Annual Growth Rate (CAGR)19.56% (2025 - 2035)
    Report CoverageRevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year2024
    Market Forecast Period2025 - 2035
    Historical Data2019 - 2024
    Market Forecast UnitsUSD Billion
    Key Companies ProfiledNovartis, Regenative Labs, Takeda Pharmaceutical, Celgene, Gilead Sciences, Abeona Therapeutics, Celerion, Amgen, UniQure, Kite Pharma, bluebird bio, Miltenyi Biotec, Vericel Corporation, Roche, BristolMyers Squibb
    Segments CoveredApplication, Cell Type, End-use, Technology, Regional
    Key Market OpportunitiesEmerging market demand, Advancements in technology, Increasing chronic disease prevalence, Growing R&D investments, Enhanced regulatory support
    Key Market DynamicsIncreasing prevalence of chronic diseases, Rising advancements in cell therapy technology, Growing demand for personalized medicine, High investment in regenerative medicine, Supportive governmental regulations and funding
    Countries CoveredNorth America, Europe, APAC, South America, MEA
    Market Size 20257.69 (USD Billion)

    Market Highlights

    Author

    Rahul Gotadki
    Assistant Manager

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM
    View All

    FAQs

    What was the market size of the Autologous Cell Therapy Market in 2024?

    The Autologous Cell Therapy Market was valued at 12.77 USD Billion in 2024.

    What is the projected market value of the Autologous Cell Therapy Market by 2035?

    By 2035, the Autologous Cell Therapy Market is projected to reach 45.0 USD Billion.

    What is the expected CAGR for the Autologous Cell Therapy Market from 2025 to 2035?

    The expected CAGR for the Autologous Cell Therapy Market from 2025 to 2035 is 12.13 percent.

    Which region is expected to dominate the Autologous Cell Therapy Market by 2035?

    North America is expected to dominate the Autologous Cell Therapy Market, with a projected value of 18.1 USD Billion by 2035.

    What will be the market size for Autologous Cell Therapy in the Oncology application by 2035?

    The market size for Autologous Cell Therapy in the Oncology application is expected to be valued at 16.2 USD Billion by 2035.

    What are the expected market values for Autologous Cell Therapy in Cardiology by 2024 and 2035?

    In 2024, the market value for Autologous Cell Therapy in Cardiology was 3.2 USD Billion, growing to 11.7 USD Billion by 2035.

    Who are some of the key players in the Autologous Cell Therapy Market?

    Key players in the Autologous Cell Therapy Market include Novartis, Regenative Labs, Takeda Pharmaceutical, and Gilead Sciences.

    What will be the expected market size for the Orthopedics application in 2035?

    The expected market size for the Orthopedics application in 2035 is projected to be 8.6 USD Billion.

    How much is the South American Autologous Cell Therapy Market expected to be valued in 2035?

    By 2035, the South American Autologous Cell Therapy Market is expected to be valued at 2.6 USD Billion.

    What growth rate can be expected for the Asia Pacific region in the Autologous Cell Therapy Market?

    The Asia Pacific region is projected to witness growth and reach a market size of 8.0 USD Billion by 2035.

    1. Table of Contents
    2. EXECUTIVE SUMMARY
    3. Market Overview
    4. Key Findings
    5. Market Segmentation
    6. Competitive Landscape
    7. Challenges and Opportunities
    8. Future Outlook
    9. MARKET INTRODUCTION
    10. Definition
    11. Scope of the study
    12. Research Objective
    13. Assumption
    14. Limitations
    15. RESEARCH METHODOLOGY
    16. Overview
    17. Data Mining
    18. Secondary Research
    19. Primary Research
    20. Primary Interviews and Information Gathering Process
    21. Breakdown of Primary Respondents
    22. Forecasting Model
    23. Market Size Estimation
    24. Bottom-Up Approach
    25. Top-Down Approach
    26. Data Triangulation
    27. Validation
    28. MARKET DYNAMICS
    29. Overview
    30. Drivers
    31. Restraints
    32. Opportunities
    33. MARKET FACTOR ANALYSIS
    34. Value chain Analysis
    35. Porter's Five Forces Analysis
    36. Bargaining Power of Suppliers
    37. Bargaining Power of Buyers
    38. Threat of New Entrants
    39. Threat of Substitutes
    40. Intensity of Rivalry
    41. COVID-19 Impact Analysis
    42. Market Impact Analysis
    43. Regional Impact
    44. Opportunity and Threat Analysis
    45. Autologous Cell Therapy Market, BY Application (USD Billion)
    46. Oncology
    47. Cardiology
    48. Orthopedics
    49. Dermatology
    50. Autologous Cell Therapy Market, BY Cell Type (USD Billion)
    51. Stem Cells
    52. T Cells
    53. Dendritic Cells
    54. Platelet Rich Plasma
    55. Autologous Cell Therapy Market, BY End Use (USD Billion)
    56. Hospitals
    57. Clinics
    58. Research Laboratories
    59. Autologous Cell Therapy Market, BY Technology (USD Billion)
    60. Cell Isolation
    61. Cell Expansion
    62. Cryopreservation
    63. Autologous Cell Therapy Market, BY Regional (USD Billion)
    64. North America
    65. US
    66. Canada
    67. Europe
    68. Germany
    69. UK
    70. France
    71. Russia
    72. Italy
    73. Spain
    74. Rest of Europe
    75. APAC
    76. China
    77. India
    78. Japan
    79. South Korea
    80. Malaysia
    81. Thailand
    82. Indonesia
    83. Rest of APAC
    84. South America
    85. Brazil
    86. Mexico
    87. Argentina
    88. Rest of South America
    89. MEA
    90. GCC Countries
    91. South Africa
    92. Rest of MEA
    93. Competitive Landscape
    94. Overview
    95. Competitive Analysis
    96. Market share Analysis
    97. Major Growth Strategy in the Autologous Cell Therapy Market
    98. Competitive Benchmarking
    99. Leading Players in Terms of Number of Developments in the Autologous Cell Therapy Market
    100. Key developments and growth strategies
    101. New Product Launch/Service Deployment
    102. Merger & Acquisitions
    103. Joint Ventures
    104. Major Players Financial Matrix
    105. Sales and Operating Income
    106. Major Players R&D Expenditure. 2023
    107. Company Profiles
    108. Takeda Pharmaceuticals
    109. Financial Overview
    110. Products Offered
    111. Key Developments
    112. SWOT Analysis
    113. Key Strategies
    114. Rocket Pharmaceuticals
    115. Financial Overview
    116. Products Offered
    117. Key Developments
    118. SWOT Analysis
    119. Key Strategies
    120. Gilead Sciences
    121. Financial Overview
    122. Products Offered
    123. Key Developments
    124. SWOT Analysis
    125. Key Strategies
    126. Kite Pharma
    127. Financial Overview
    128. Products Offered
    129. Key Developments
    130. SWOT Analysis
    131. Key Strategies
    132. Johnson and Johnson
    133. Financial Overview
    134. Products Offered
    135. Key Developments
    136. SWOT Analysis
    137. Key Strategies
    138. Novartis
    139. Financial Overview
    140. Products Offered
    141. Key Developments
    142. SWOT Analysis
    143. Key Strategies
    144. Celgene
    145. Financial Overview
    146. Products Offered
    147. Key Developments
    148. SWOT Analysis
    149. Key Strategies
    150. Fate Therapeutics
    151. Financial Overview
    152. Products Offered
    153. Key Developments
    154. SWOT Analysis
    155. Key Strategies
    156. Regeneron Pharmaceuticals
    157. Financial Overview
    158. Products Offered
    159. Key Developments
    160. SWOT Analysis
    161. Key Strategies
    162. Medpace Holdings
    163. Financial Overview
    164. Products Offered
    165. Key Developments
    166. SWOT Analysis
    167. Key Strategies
    168. Medtronic
    169. Financial Overview
    170. Products Offered
    171. Key Developments
    172. SWOT Analysis
    173. Key Strategies
    174. BristolMyers Squibb
    175. Financial Overview
    176. Products Offered
    177. Key Developments
    178. SWOT Analysis
    179. Key Strategies
    180. Bluebird Bio
    181. Financial Overview
    182. Products Offered
    183. Key Developments
    184. SWOT Analysis
    185. Key Strategies
    186. Amgen
    187. Financial Overview
    188. Products Offered
    189. Key Developments
    190. SWOT Analysis
    191. Key Strategies
    192. Celyad Oncology
    193. Financial Overview
    194. Products Offered
    195. Key Developments
    196. SWOT Analysis
    197. Key Strategies
    198. Appendix
    199. References
    200. Related Reports

    Autologous Cell Therapy Market Segmentation

     

    Autologous Cell Therapy Market By Application (USD Billion, 2019-2035)

    Oncology

    Cardiology

    Orthopedics

    Dermatology

     

    Autologous Cell Therapy Market By Cell Type (USD Billion, 2019-2035)

    Stem Cells

    T Cells

    Dendritic Cells

    Platelet Rich Plasma

     

    Autologous Cell Therapy Market By End Use (USD Billion, 2019-2035)

    Hospitals

    Clinics

    Research Laboratories

     

    Autologous Cell Therapy Market By Technology (USD Billion, 2019-2035)

    Cell Isolation

    Cell Expansion

    Cryopreservation

     

    Autologous Cell Therapy Market By Regional (USD Billion, 2019-2035)

    North America

    Europe

    South America

    Asia Pacific

    Middle East and Africa

     

    Autologous Cell Therapy Market Regional Outlook (USD Billion, 2019-2035)

     

     

    North America Outlook (USD Billion, 2019-2035)

    North America Autologous Cell Therapy Market by Application Type

    Oncology

    Cardiology

    Orthopedics

    Dermatology

    North America Autologous Cell Therapy Market by Cell Type

    Stem Cells

    T Cells

    Dendritic Cells

    Platelet Rich Plasma

    North America Autologous Cell Therapy Market by End Use Type

    Hospitals

    Clinics

    Research Laboratories

    North America Autologous Cell Therapy Market by Technology Type

    Cell Isolation

    Cell Expansion

    Cryopreservation

    North America Autologous Cell Therapy Market by Regional Type

    US

    Canada

    US Outlook (USD Billion, 2019-2035)

    US Autologous Cell Therapy Market by Application Type

    Oncology

    Cardiology

    Orthopedics

    Dermatology

    US Autologous Cell Therapy Market by Cell Type

    Stem Cells

    T Cells

    Dendritic Cells

    Platelet Rich Plasma

    US Autologous Cell Therapy Market by End Use Type

    Hospitals

    Clinics

    Research Laboratories

    US Autologous Cell Therapy Market by Technology Type

    Cell Isolation

    Cell Expansion

    Cryopreservation

    CANADA Outlook (USD Billion, 2019-2035)

    CANADA Autologous Cell Therapy Market by Application Type

    Oncology

    Cardiology

    Orthopedics

    Dermatology

    CANADA Autologous Cell Therapy Market by Cell Type

    Stem Cells

    T Cells

    Dendritic Cells

    Platelet Rich Plasma

    CANADA Autologous Cell Therapy Market by End Use Type

    Hospitals

    Clinics

    Research Laboratories

    CANADA Autologous Cell Therapy Market by Technology Type

    Cell Isolation

    Cell Expansion

    Cryopreservation

    Europe Outlook (USD Billion, 2019-2035)

    Europe Autologous Cell Therapy Market by Application Type

    Oncology

    Cardiology

    Orthopedics

    Dermatology

    Europe Autologous Cell Therapy Market by Cell Type

    Stem Cells

    T Cells

    Dendritic Cells

    Platelet Rich Plasma

    Europe Autologous Cell Therapy Market by End Use Type

    Hospitals

    Clinics

    Research Laboratories

    Europe Autologous Cell Therapy Market by Technology Type

    Cell Isolation

    Cell Expansion

    Cryopreservation

    Europe Autologous Cell Therapy Market by Regional Type

    Germany

    UK

    France

    Russia

    Italy

    Spain

    Rest of Europe

    GERMANY Outlook (USD Billion, 2019-2035)

    GERMANY Autologous Cell Therapy Market by Application Type

    Oncology

    Cardiology

    Orthopedics

    Dermatology

    GERMANY Autologous Cell Therapy Market by Cell Type

    Stem Cells

    T Cells

    Dendritic Cells

    Platelet Rich Plasma

    GERMANY Autologous Cell Therapy Market by End Use Type

    Hospitals

    Clinics

    Research Laboratories

    GERMANY Autologous Cell Therapy Market by Technology Type

    Cell Isolation

    Cell Expansion

    Cryopreservation

    UK Outlook (USD Billion, 2019-2035)

    UK Autologous Cell Therapy Market by Application Type

    Oncology

    Cardiology

    Orthopedics

    Dermatology

    UK Autologous Cell Therapy Market by Cell Type

    Stem Cells

    T Cells

    Dendritic Cells

    Platelet Rich Plasma

    UK Autologous Cell Therapy Market by End Use Type

    Hospitals

    Clinics

    Research Laboratories

    UK Autologous Cell Therapy Market by Technology Type

    Cell Isolation

    Cell Expansion

    Cryopreservation

    FRANCE Outlook (USD Billion, 2019-2035)

    FRANCE Autologous Cell Therapy Market by Application Type

    Oncology

    Cardiology

    Orthopedics

    Dermatology

    FRANCE Autologous Cell Therapy Market by Cell Type

    Stem Cells

    T Cells

    Dendritic Cells

    Platelet Rich Plasma

    FRANCE Autologous Cell Therapy Market by End Use Type

    Hospitals

    Clinics

    Research Laboratories

    FRANCE Autologous Cell Therapy Market by Technology Type

    Cell Isolation

    Cell Expansion

    Cryopreservation

    RUSSIA Outlook (USD Billion, 2019-2035)

    RUSSIA Autologous Cell Therapy Market by Application Type

    Oncology

    Cardiology

    Orthopedics

    Dermatology

    RUSSIA Autologous Cell Therapy Market by Cell Type

    Stem Cells

    T Cells

    Dendritic Cells

    Platelet Rich Plasma

    RUSSIA Autologous Cell Therapy Market by End Use Type

    Hospitals

    Clinics

    Research Laboratories

    RUSSIA Autologous Cell Therapy Market by Technology Type

    Cell Isolation

    Cell Expansion

    Cryopreservation

    ITALY Outlook (USD Billion, 2019-2035)

    ITALY Autologous Cell Therapy Market by Application Type

    Oncology

    Cardiology

    Orthopedics

    Dermatology

    ITALY Autologous Cell Therapy Market by Cell Type

    Stem Cells

    T Cells

    Dendritic Cells

    Platelet Rich Plasma

    ITALY Autologous Cell Therapy Market by End Use Type

    Hospitals

    Clinics

    Research Laboratories

    ITALY Autologous Cell Therapy Market by Technology Type

    Cell Isolation

    Cell Expansion

    Cryopreservation

    SPAIN Outlook (USD Billion, 2019-2035)

    SPAIN Autologous Cell Therapy Market by Application Type

    Oncology

    Cardiology

    Orthopedics

    Dermatology

    SPAIN Autologous Cell Therapy Market by Cell Type

    Stem Cells

    T Cells

    Dendritic Cells

    Platelet Rich Plasma

    SPAIN Autologous Cell Therapy Market by End Use Type

    Hospitals

    Clinics

    Research Laboratories

    SPAIN Autologous Cell Therapy Market by Technology Type

    Cell Isolation

    Cell Expansion

    Cryopreservation

    REST OF EUROPE Outlook (USD Billion, 2019-2035)

    REST OF EUROPE Autologous Cell Therapy Market by Application Type

    Oncology

    Cardiology

    Orthopedics

    Dermatology

    REST OF EUROPE Autologous Cell Therapy Market by Cell Type

    Stem Cells

    T Cells

    Dendritic Cells

    Platelet Rich Plasma

    REST OF EUROPE Autologous Cell Therapy Market by End Use Type

    Hospitals

    Clinics

    Research Laboratories

    REST OF EUROPE Autologous Cell Therapy Market by Technology Type

    Cell Isolation

    Cell Expansion

    Cryopreservation

    APAC Outlook (USD Billion, 2019-2035)

    APAC Autologous Cell Therapy Market by Application Type

    Oncology

    Cardiology

    Orthopedics

    Dermatology

    APAC Autologous Cell Therapy Market by Cell Type

    Stem Cells

    T Cells

    Dendritic Cells

    Platelet Rich Plasma

    APAC Autologous Cell Therapy Market by End Use Type

    Hospitals

    Clinics

    Research Laboratories

    APAC Autologous Cell Therapy Market by Technology Type

    Cell Isolation

    Cell Expansion

    Cryopreservation

    APAC Autologous Cell Therapy Market by Regional Type

    China

    India

    Japan

    South Korea

    Malaysia

    Thailand

    Indonesia

    Rest of APAC

    CHINA Outlook (USD Billion, 2019-2035)

    CHINA Autologous Cell Therapy Market by Application Type

    Oncology

    Cardiology

    Orthopedics

    Dermatology

    CHINA Autologous Cell Therapy Market by Cell Type

    Stem Cells

    T Cells

    Dendritic Cells

    Platelet Rich Plasma

    CHINA Autologous Cell Therapy Market by End Use Type

    Hospitals

    Clinics

    Research Laboratories

    CHINA Autologous Cell Therapy Market by Technology Type

    Cell Isolation

    Cell Expansion

    Cryopreservation

    INDIA Outlook (USD Billion, 2019-2035)

    INDIA Autologous Cell Therapy Market by Application Type

    Oncology

    Cardiology

    Orthopedics

    Dermatology

    INDIA Autologous Cell Therapy Market by Cell Type

    Stem Cells

    T Cells

    Dendritic Cells

    Platelet Rich Plasma

    INDIA Autologous Cell Therapy Market by End Use Type

    Hospitals

    Clinics

    Research Laboratories

    INDIA Autologous Cell Therapy Market by Technology Type

    Cell Isolation

    Cell Expansion

    Cryopreservation

    JAPAN Outlook (USD Billion, 2019-2035)

    JAPAN Autologous Cell Therapy Market by Application Type

    Oncology

    Cardiology

    Orthopedics

    Dermatology

    JAPAN Autologous Cell Therapy Market by Cell Type

    Stem Cells

    T Cells

    Dendritic Cells

    Platelet Rich Plasma

    JAPAN Autologous Cell Therapy Market by End Use Type

    Hospitals

    Clinics

    Research Laboratories

    JAPAN Autologous Cell Therapy Market by Technology Type

    Cell Isolation

    Cell Expansion

    Cryopreservation

    SOUTH KOREA Outlook (USD Billion, 2019-2035)

    SOUTH KOREA Autologous Cell Therapy Market by Application Type

    Oncology

    Cardiology

    Orthopedics

    Dermatology

    SOUTH KOREA Autologous Cell Therapy Market by Cell Type

    Stem Cells

    T Cells

    Dendritic Cells

    Platelet Rich Plasma

    SOUTH KOREA Autologous Cell Therapy Market by End Use Type

    Hospitals

    Clinics

    Research Laboratories

    SOUTH KOREA Autologous Cell Therapy Market by Technology Type

    Cell Isolation

    Cell Expansion

    Cryopreservation

    MALAYSIA Outlook (USD Billion, 2019-2035)

    MALAYSIA Autologous Cell Therapy Market by Application Type

    Oncology

    Cardiology

    Orthopedics

    Dermatology

    MALAYSIA Autologous Cell Therapy Market by Cell Type

    Stem Cells

    T Cells

    Dendritic Cells

    Platelet Rich Plasma

    MALAYSIA Autologous Cell Therapy Market by End Use Type

    Hospitals

    Clinics

    Research Laboratories

    MALAYSIA Autologous Cell Therapy Market by Technology Type

    Cell Isolation

    Cell Expansion

    Cryopreservation

    THAILAND Outlook (USD Billion, 2019-2035)

    THAILAND Autologous Cell Therapy Market by Application Type

    Oncology

    Cardiology

    Orthopedics

    Dermatology

    THAILAND Autologous Cell Therapy Market by Cell Type

    Stem Cells

    T Cells

    Dendritic Cells

    Platelet Rich Plasma

    THAILAND Autologous Cell Therapy Market by End Use Type

    Hospitals

    Clinics

    Research Laboratories

    THAILAND Autologous Cell Therapy Market by Technology Type

    Cell Isolation

    Cell Expansion

    Cryopreservation

    INDONESIA Outlook (USD Billion, 2019-2035)

    INDONESIA Autologous Cell Therapy Market by Application Type

    Oncology

    Cardiology

    Orthopedics

    Dermatology

    INDONESIA Autologous Cell Therapy Market by Cell Type

    Stem Cells

    T Cells

    Dendritic Cells

    Platelet Rich Plasma

    INDONESIA Autologous Cell Therapy Market by End Use Type

    Hospitals

    Clinics

    Research Laboratories

    INDONESIA Autologous Cell Therapy Market by Technology Type

    Cell Isolation

    Cell Expansion

    Cryopreservation

    REST OF APAC Outlook (USD Billion, 2019-2035)

    REST OF APAC Autologous Cell Therapy Market by Application Type

    Oncology

    Cardiology

    Orthopedics

    Dermatology

    REST OF APAC Autologous Cell Therapy Market by Cell Type

    Stem Cells

    T Cells

    Dendritic Cells

    Platelet Rich Plasma

    REST OF APAC Autologous Cell Therapy Market by End Use Type

    Hospitals

    Clinics

    Research Laboratories

    REST OF APAC Autologous Cell Therapy Market by Technology Type

    Cell Isolation

    Cell Expansion

    Cryopreservation

    South America Outlook (USD Billion, 2019-2035)

    South America Autologous Cell Therapy Market by Application Type

    Oncology

    Cardiology

    Orthopedics

    Dermatology

    South America Autologous Cell Therapy Market by Cell Type

    Stem Cells

    T Cells

    Dendritic Cells

    Platelet Rich Plasma

    South America Autologous Cell Therapy Market by End Use Type

    Hospitals

    Clinics

    Research Laboratories

    South America Autologous Cell Therapy Market by Technology Type

    Cell Isolation

    Cell Expansion

    Cryopreservation

    South America Autologous Cell Therapy Market by Regional Type

    Brazil

    Mexico

    Argentina

    Rest of South America

    BRAZIL Outlook (USD Billion, 2019-2035)

    BRAZIL Autologous Cell Therapy Market by Application Type

    Oncology

    Cardiology

    Orthopedics

    Dermatology

    BRAZIL Autologous Cell Therapy Market by Cell Type

    Stem Cells

    T Cells

    Dendritic Cells

    Platelet Rich Plasma

    BRAZIL Autologous Cell Therapy Market by End Use Type

    Hospitals

    Clinics

    Research Laboratories

    BRAZIL Autologous Cell Therapy Market by Technology Type

    Cell Isolation

    Cell Expansion

    Cryopreservation

    MEXICO Outlook (USD Billion, 2019-2035)

    MEXICO Autologous Cell Therapy Market by Application Type

    Oncology

    Cardiology

    Orthopedics

    Dermatology

    MEXICO Autologous Cell Therapy Market by Cell Type

    Stem Cells

    T Cells

    Dendritic Cells

    Platelet Rich Plasma

    MEXICO Autologous Cell Therapy Market by End Use Type

    Hospitals

    Clinics

    Research Laboratories

    MEXICO Autologous Cell Therapy Market by Technology Type

    Cell Isolation

    Cell Expansion

    Cryopreservation

    ARGENTINA Outlook (USD Billion, 2019-2035)

    ARGENTINA Autologous Cell Therapy Market by Application Type

    Oncology

    Cardiology

    Orthopedics

    Dermatology

    ARGENTINA Autologous Cell Therapy Market by Cell Type

    Stem Cells

    T Cells

    Dendritic Cells

    Platelet Rich Plasma

    ARGENTINA Autologous Cell Therapy Market by End Use Type

    Hospitals

    Clinics

    Research Laboratories

    ARGENTINA Autologous Cell Therapy Market by Technology Type

    Cell Isolation

    Cell Expansion

    Cryopreservation

    REST OF SOUTH AMERICA Outlook (USD Billion, 2019-2035)

    REST OF SOUTH AMERICA Autologous Cell Therapy Market by Application Type

    Oncology

    Cardiology

    Orthopedics

    Dermatology

    REST OF SOUTH AMERICA Autologous Cell Therapy Market by Cell Type

    Stem Cells

    T Cells

    Dendritic Cells

    Platelet Rich Plasma

    REST OF SOUTH AMERICA Autologous Cell Therapy Market by End Use Type

    Hospitals

    Clinics

    Research Laboratories

    REST OF SOUTH AMERICA Autologous Cell Therapy Market by Technology Type

    Cell Isolation

    Cell Expansion

    Cryopreservation

    MEA Outlook (USD Billion, 2019-2035)

    MEA Autologous Cell Therapy Market by Application Type

    Oncology

    Cardiology

    Orthopedics

    Dermatology

    MEA Autologous Cell Therapy Market by Cell Type

    Stem Cells

    T Cells

    Dendritic Cells

    Platelet Rich Plasma

    MEA Autologous Cell Therapy Market by End Use Type

    Hospitals

    Clinics

    Research Laboratories

    MEA Autologous Cell Therapy Market by Technology Type

    Cell Isolation

    Cell Expansion

    Cryopreservation

    MEA Autologous Cell Therapy Market by Regional Type

    GCC Countries

    South Africa

    Rest of MEA

    GCC COUNTRIES Outlook (USD Billion, 2019-2035)

    GCC COUNTRIES Autologous Cell Therapy Market by Application Type

    Oncology

    Cardiology

    Orthopedics

    Dermatology

    GCC COUNTRIES Autologous Cell Therapy Market by Cell Type

    Stem Cells

    T Cells

    Dendritic Cells

    Platelet Rich Plasma

    GCC COUNTRIES Autologous Cell Therapy Market by End Use Type

    Hospitals

    Clinics

    Research Laboratories

    GCC COUNTRIES Autologous Cell Therapy Market by Technology Type

    Cell Isolation

    Cell Expansion

    Cryopreservation

    SOUTH AFRICA Outlook (USD Billion, 2019-2035)

    SOUTH AFRICA Autologous Cell Therapy Market by Application Type

    Oncology

    Cardiology

    Orthopedics

    Dermatology

    SOUTH AFRICA Autologous Cell Therapy Market by Cell Type

    Stem Cells

    T Cells

    Dendritic Cells

    Platelet Rich Plasma

    SOUTH AFRICA Autologous Cell Therapy Market by End Use Type

    Hospitals

    Clinics

    Research Laboratories

    SOUTH AFRICA Autologous Cell Therapy Market by Technology Type

    Cell Isolation

    Cell Expansion

    Cryopreservation

    REST OF MEA Outlook (USD Billion, 2019-2035)

    REST OF MEA Autologous Cell Therapy Market by Application Type

    Oncology

    Cardiology

    Orthopedics

    Dermatology

    REST OF MEA Autologous Cell Therapy Market by Cell Type

    Stem Cells

    T Cells

    Dendritic Cells

    Platelet Rich Plasma

    REST OF MEA Autologous Cell Therapy Market by End Use Type

    Hospitals

    Clinics

    Research Laboratories

    REST OF MEA Autologous Cell Therapy Market by Technology Type

    Cell Isolation

    Cell Expansion

    Cryopreservation

     

     

    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Related Reports

    Regional Reports
    Country Reports

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials
    Global Magnesium Sulfate Market – Forecast till 2027